7,900 Shares in Philip Morris International Inc. $PM Purchased by Element Capital Management LLC

Element Capital Management LLC acquired a new stake in Philip Morris International Inc. (NYSE:PM - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,900 shares of the company's stock, valued at approximately $1,429,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of PM. Capital World Investors grew its position in shares of Philip Morris International by 2.8% in the 4th quarter. Capital World Investors now owns 132,355,726 shares of the company's stock worth $21,230,315,000 after acquiring an additional 3,579,399 shares in the last quarter. BlackRock Inc. raised its position in shares of Philip Morris International by 0.4% during the 2nd quarter. BlackRock Inc. now owns 108,039,522 shares of the company's stock valued at $19,545,430,000 after acquiring an additional 444,449 shares in the last quarter. Capital International Investors raised its position in shares of Philip Morris International by 13.7% during the 4th quarter. Capital International Investors now owns 101,377,875 shares of the company's stock valued at $16,262,967,000 after acquiring an additional 12,227,004 shares in the last quarter. Capital Research Global Investors lifted its stake in Philip Morris International by 25.3% during the fourth quarter. Capital Research Global Investors now owns 54,559,706 shares of the company's stock worth $8,751,407,000 after purchasing an additional 11,013,173 shares during the last quarter. Finally, GQG Partners LLC bought a new position in Philip Morris International during the second quarter worth $8,220,008,000. Institutional investors and hedge funds own 78.63% of the company's stock.

Key Philip Morris International News

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: FDA authorization strengthens ZYN growth prospects. The FDA authorized 11 ZYN ULTRA nicotine-pouch products, expanding PM’s U.S. smoke-free portfolio and supporting its longer-term shift away from combustible tobacco. Smoke-free products, led by ZYN and IQOS, now account for more than 41% of revenue, offering a potential multiyear growth runway. Philip Morris’ ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
• Positive Sentiment: Manufacturing agreements with Altria may improve efficiency. PM and Altria entered reciprocal contract-manufacturing arrangements involving cigarette production. The agreements should increase operational flexibility and manufacturing efficiency, with initial shipments expected in 2027. The partnership may provide longer-term cost and supply-chain benefits for PM, despite limited near-term earnings impact. Altria and Philip Morris International Sign Contract Manufacturing Deals
• Positive Sentiment: Pricing power and shareholder returns remain supportive. PM’s portfolio spans IQOS, ZYN, VEEV One, and Marlboro, helping it maintain premium pricing amid uncertain economic conditions. Analysts highlight strong free cash flow, lower debt leverage, and the possibility of another dividend increase in September. Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets
• Neutral Sentiment: Near-term financial impact from the Altria deal is expected to be limited. Both companies said the manufacturing arrangements are not expected to materially affect 2026 results, so investors may need to wait until 2027 for measurable benefits. Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
• Negative Sentiment: Valuation leaves less room for disappointment. PM’s smoke-free growth and defensive cash flows have attracted a premium valuation, creating downside risk if product adoption, regulatory momentum, or earnings growth falls short of expectations.

Philip Morris International Stock Up 1.3%

Shares of NYSE:PM opened at $194.00 on Wednesday. The company has a market cap of $302.36 billion, a PE ratio of 27.87, a P/E/G ratio of 2.31 and a beta of 0.38. The company's 50-day moving average price is $186.42 and its 200 day moving average price is $178.55. Philip Morris International Inc. has a fifty-two week low of $142.11 and a fifty-two week high of $207.76.

Philip Morris International (NYSE:PM - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The company reported $2.20 EPS for the quarter, topping the consensus estimate of $2.05 by $0.15. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The firm had revenue of $11.19 billion during the quarter, compared to analysts' expectations of $10.60 billion. During the same quarter in the prior year, the firm earned $1.89 EPS. Philip Morris International's quarterly revenue was up 10.4% on a year-over-year basis. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. As a group, equities analysts anticipate that Philip Morris International Inc. will post 8.33 EPS for the current year.

Philip Morris International Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were issued a $1.47 dividend. This represents a $5.88 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International's dividend payout ratio is 84.48%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on PM. BTIG Research set a $221.00 target price on shares of Philip Morris International and gave the company a "buy" rating in a research note on Friday, July 24th. Needham & Company LLC lifted their price target on shares of Philip Morris International from $200.00 to $215.00 and gave the company a "buy" rating in a report on Thursday, July 23rd. Morgan Stanley increased their price objective on shares of Philip Morris International from $200.00 to $215.00 and gave the stock an "overweight" rating in a research note on Thursday, July 23rd. Bank of America reissued a "buy" rating on shares of Philip Morris International in a report on Thursday, May 21st. Finally, Barclays lifted their target price on Philip Morris International from $205.00 to $225.00 and gave the company an "overweight" rating in a research note on Wednesday, July 29th. Ten analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $205.89.

Philip Morris International Company Profile

Philip Morris International Inc NYSE: PM is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI's product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source